-
1Report
المؤلفون: Bochmann, J., Muecke, M., Langfahl-Klabes, G., Erbel, C., Weber, B., Specht, H. P., Moehring, D. L., Rempe, G.
المصدر: Phys. Rev. Lett. 101, 223601 (2008)
مصطلحات موضوعية: Quantum Physics
URL الوصول: http://arxiv.org/abs/0806.2600
-
2Academic Journal
المؤلفون: Kronlage M, Wassmann M, Vogel B, Müller OJ, Blessing E, Katus H, Erbel C
المصدر: Drug Design, Development and Therapy, Vol Volume 11, Pp 2937-2945 (2017)
مصطلحات موضوعية: Peripheral artery disease, stent implantation, dual antiplatelet therapy, primary patency, endovascular therapy, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: Kronlage M, Printz I, Vogel B, Blessing E, Müller OJ, Katus HA, Erbel C
المصدر: Drug Design, Development and Therapy, Vol Volume 11, Pp 1233-1241 (2017)
مصطلحات موضوعية: acute limb ischemia, thrombolysis, mechanical thrombectomy, Rotarex®, arterial thrombosis and embolism, acute artery occlusion, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
4Academic Journal
المؤلفون: Rivinius R, Helmschrott M, Ruhparwar A, Erbel C, Gleissner CA, Darche FF, Thomas D, Bruckner T, Katus HA, Doesch AO
المصدر: Therapeutics and Clinical Risk Management, Vol Volume 13, Pp 287-297 (2017)
مصطلحات موضوعية: Atrial fibrillation, biatrial heart transplantation, bicaval heart transplantation, mortality, surgical technique, total orthotopic heart transplantation, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
5Academic Journal
المؤلفون: Rivinius R, Helmschrott M, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Darche FF, Schweizer PA, Thomas D, Ehlermann P, Bruckner T, Katus HA, Doesch AO
المصدر: Drug Design, Development and Therapy, Vol 2016, Iss Issue 1, Pp 677-686 (2016)
مصطلحات موضوعية: amiodarone, atrial fibrillation, heart failure, heart transplantation, mortality, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
6Academic Journal
المؤلفون: Helmschrott M, Rivinius R, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Ehlermann P, Bruckner T, Katus HA, Doesch AO
المصدر: Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 1217-1224 (2015)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
7Academic Journal
المؤلفون: Rivinius R, Helmschrott M, Ruhparwar A, Schmack B, Klein B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Darche FF, Thomas D, Ehlermann P, Bruckner T, Katus HA, Doesch AO
المصدر: Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 93-102 (2014)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
8Academic Journal
المؤلفون: Akhavanpoor M, Gleissner CA, Gorbatsch S, Doesch AO, Akhavanpoor H, Wangler S, Jahn F, Lasitschka F, Katus HA, Erbel C
المصدر: Drug Design, Development and Therapy, Vol 2014, Iss default, Pp 2359-2371 (2014)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
9Academic Journal
المؤلفون: Helmschrott M, Beckendorf J, Akyol C, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Ehlermann P, Bruckner T, Katus HA, Doesch AO
المصدر: Drug Design, Development and Therapy, Vol 2014, Iss default, Pp 1307-1314 (2014)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
10Academic Journal
المؤلفون: Doesch AO, Zhao L, Gleissner CA, Akhavanpoor M, Rohde D, Okuyucu D, Hakimi M, Dengler TJ, Katus HA, Erbel C
المصدر: Drug Design, Development and Therapy, Vol 2014, Iss default, Pp 447-457 (2014)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
11Academic Journal
المؤلفون: Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA
المصدر: Drug Design, Development and Therapy, Vol 2013, Iss default, Pp 1323-1328 (2013)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
12Academic Journal
المؤلفون: Kraeuter M, Helmschrott M, Erbel C, Gleissner CA, Frankenstein L, Schmack B, Ruhparwar A, Ehlermann P, Katus HA, Doesch AO
المصدر: Drug Design, Development and Therapy, Vol 2013, Iss default, Pp 1421-1426 (2013)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
13Academic Journal
المؤلفون: Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA
المصدر: Drug Design, Development and Therapy, Vol 2013, Iss default, Pp 1253-1258 (2013)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
14Academic Journal
المؤلفون: Gueler I, Mueller S, Helmschrott M, Oeing CU, Erbel C, Frankenstein L, Gleissner C, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA, Doesch AO
المصدر: Drug Design, Development and Therapy, Vol 2013, Iss default, Pp 297-303 (2013)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
15Academic Journal
المؤلفون: Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA
المصدر: Drug Design, Development and Therapy, Vol 2012, Iss default, Pp 289-295 (2012)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
16Academic Journal
المؤلفون: Langhoff, R., Schulte, K.-L., Amendt, K., Erbel, C., Hardung, D., Nikol, S., Tiefenbacher, C.
المصدر: Der Kardiologe ; volume 16, issue 2, page 164-177 ; ISSN 1864-9718 1864-9726
-
17Conference
المؤلفون: Gleissner, CA, Shaked, I, Erbel, C, Böckler, D, Katus, HA, Ley, E
المصدر: 24. Jahrestagung der Deutschen Gesellschaft für Arterioskleroseforschung; 20100318-20100320; Blaubeuren; DOC10dgaf16 /20110323/
مصطلحات موضوعية: ddc: 610
Relation: Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, Enav B, Shehadeh N, Kanter Y, Lache O, Cohen O, Levy NS, Levy AP. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ Res. 2003;92(11):1193-1200. DOI:10.1161/01.RES.0000076889.23082.F1; Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007;6(2):137-43. DOI:10.1016/j.cmet.2007.06.010; Ishikawa K, Sugawara D, Wang X-p, Suzuki K, Itabe H, Maruyama Y, Lusis AJ. Heme Oxygenase-1 Inhibits Atherosclerotic Lesion Formation in LDL-Receptor Knockout Mice. Circ Res. 2001;88(5):506-12.; Juan S-H, Lee T-S, Tseng K-W, Liou J-Y, Shyue S-K, Wu KK, Chau L-Y. Adenovirus-Mediated Heme Oxygenase-1 Gene Transfer Inhibits the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation. 2001;104(13):1519-25. DOI:10.1161/hc3801.095663; Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med. 2009;15(1):97-103. DOI:10.1038/nm.1898; Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature. 2001;409(6817):198-201. DOI:10.1038/35051594; Levy AP, Purushothaman KR, Levy NS, Purushothaman M, Strauss M, Asleh R, Marsh S, Cohen O, Moestrup SK, Moller HJ, Zias EA, Benhayon D, Fuster V, Moreno PR. Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability. Circ Res. 2007;101(1):106-10. DOI:10.1161/CIRCRESAHA.107.149435; Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med. 2002;8(11):1235-42. DOI:10.1038/nm1102-1235; Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong J, Deshane J, Bolisetty S, Shaposhnik Z, Shih DM, Agarwal A, Lusis AJ, Araujo JA. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res. 2007;100(12):1703-11. DOI:10.1161/CIRCRESAHA.107.151720; Pitsilos S, Hunt J, Mohler ER, Prabhakar AM, Poncz M, Dawicki J, Khalapyan TZ, Wolfe ML, Fairman R, Mitchell M, Carpenter J, Golden MA, Cines DB, Sachais BS. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost. 2003;90(6):1112-20.; Rucinski B, Niewiarowski S, Strzyzewski M, Holt JC, Mayo KH. Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation. Thromb Haemost. 1990;63(3):493-98.; Sachais BS, Turrentine T, Dawicki McKenna JM, Rux AH, Rader D, Kowalska MA. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice. Thromb Haemost. 2007;98(5):1108-13.; Scheuerer B, Ernst M, Durrbaum-Landmann I, Fleischer J, Grage-Griebenow E, Brandt E, Flad HD, Petersen F. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood. 2000;95(4):1158-66.; Waldo SW, Li Y, Buono C, Zhao B, Billings EM, Chang J, Kruth HS. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol. 2008;172(4):1112-26. DOI:10.2353/ajpath.2008.070513; http://dx.doi.org/10.3205/10dgaf16; http://nbn-resolving.de/urn:nbn:de:0183-10dgaf161; http://www.egms.de/en/meetings/dgaf2010/10dgaf16.shtml
-
18Conference
المؤلفون: Erbel, C, Wangler, S, Dengler, TJ, Bea, F, Wambsganss, N, Hakimi, M, Böckler, D, Katus, HA, Gleissner, CA
المصدر: 24. Jahrestagung der Deutschen Gesellschaft für Arterioskleroseforschung; 20100318-20100320; Blaubeuren; DOC10dgaf03 /20110323/
مصطلحات موضوعية: ddc: 610
Relation: Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation. 1990;82:II38-46.; Erbel C, Sato K, Meyer FB, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol. 2007;102:123-32. DOI:10.1007/s00395-006-0636-x; Erbel C, Chen L, Bea F, Wangler S, Celik S, Lasitschka F, Wang Y, Bockler D, Katus HA, Dengler TJ. Inhibition of IL-17A attenuates atherosclerotic lesion development in ApoE-deficient mice. J Immunol. 2009;183:8167-75. DOI:10.4049/jimmunol.0901126; Gravallese EM. Osteopontin: a bridge between bone and the immune system. J Clin Invest. 2003;112:147-9.; Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508-19. DOI:10.1038/nri1882; Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB, Oukka M, Kuchroo VK. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448:484-7. DOI:10.1038/nature05970; Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233-40. DOI:10.1084/jem.20041257; Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13-8. DOI:10.1016/j.jacc.2005.10.065; Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821-52. DOI:10.1146/annurev.immunol.25.022106.141557; http://dx.doi.org/10.3205/10dgaf03; http://nbn-resolving.de/urn:nbn:de:0183-10dgaf035; http://www.egms.de/en/meetings/dgaf2010/10dgaf03.shtml
-
19Academic Journal
المؤلفون: Helmschrott M, Rivinius R, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Ehlermann P, Bruckner T, Katus HA, Doesch AO
المصدر: Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 1217-1224 (2015)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
-
20Academic Journal
المؤلفون: Rivinius R, Helmschrott M, Ruhparwar A, Schmack B, Klein B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Darche FF, Thomas D, Ehlermann P, Bruckner T, Katus HA, Doesch AO
المصدر: Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 93-102 (2014)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950